Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ward

Showing results (1271-1280 of 1,525) with videos related to

Pageof 153
Sort By:
Cell Reports|November 24, 2024
Modulating the immunodominance hierarchy of immunoglobulin germline-encoded structural motifs targeting the influenza hemagglutinin stemSila Ataca, Maya Sangesland, Rebeca de Paiva Fróes Rocha, et al.
Nature Biotechnology|June 13, 2017
Computational design of trimeric influenza-neutralizing proteins targeting the hemagglutinin receptor binding siteEva-Maria Strauch, Steffen M Bernard, David La, et al.
The Journal of Clinical Investigation|June 22, 2021
Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interfaceSeth J Zost, Jinhui Dong, Iuliia M Gilchuk, et al.
Plos Pathogens|December 11, 2024
Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progressionMarloes Grobben, Margreet Bakker, Angela I Schriek, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144Sammaiah Pallerla, Shaunak Uplekar, Ferenc Boldog, et al.
Iscience|August 16, 2022
Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathwaysFangzhu Zhao, Celina Keating, Gabriel Ozorowski, et al.
Plos Pathogens|September 27, 2013
A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodiesRogier W Sanders, Ronald Derking, Albert Cupo, et al.
JAMA|October 23, 1997
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testingD Shattuck-Eidens, A Oliphant, M McClure, et al.
Nature Communications|December 11, 2025
Structural and immunological characterization of the H3 influenza hemagglutinin during antigenic driftRebeca de Paiva Froes Rocha, Ilhan Tomris, Charles A Bowman, et al.
Cell|June 5, 2026
Replaying germinal center evolution on a quantified affinity landscapeWilliam S DeWitt, Ashni A Vora, Tatsuya Araki, et al.
Pageof 153

Showing results (1271-1280 of 1,525) with videos related to

Sort By:
Pageof 153
Cell Reports|November 24, 2024
Modulating the immunodominance hierarchy of immunoglobulin germline-encoded structural motifs targeting the influenza hemagglutinin stemSila Ataca, Maya Sangesland, Rebeca de Paiva Fróes Rocha, et al.
Nature Biotechnology|June 13, 2017
Computational design of trimeric influenza-neutralizing proteins targeting the hemagglutinin receptor binding siteEva-Maria Strauch, Steffen M Bernard, David La, et al.
The Journal of Clinical Investigation|June 22, 2021
Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interfaceSeth J Zost, Jinhui Dong, Iuliia M Gilchuk, et al.
Plos Pathogens|December 11, 2024
Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progressionMarloes Grobben, Margreet Bakker, Angela I Schriek, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144Sammaiah Pallerla, Shaunak Uplekar, Ferenc Boldog, et al.
Iscience|August 16, 2022
Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathwaysFangzhu Zhao, Celina Keating, Gabriel Ozorowski, et al.
Plos Pathogens|September 27, 2013
A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodiesRogier W Sanders, Ronald Derking, Albert Cupo, et al.
JAMA|October 23, 1997
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testingD Shattuck-Eidens, A Oliphant, M McClure, et al.
Nature Communications|December 11, 2025
Structural and immunological characterization of the H3 influenza hemagglutinin during antigenic driftRebeca de Paiva Froes Rocha, Ilhan Tomris, Charles A Bowman, et al.
Cell|June 5, 2026
Replaying germinal center evolution on a quantified affinity landscapeWilliam S DeWitt, Ashni A Vora, Tatsuya Araki, et al.
Pageof 153